Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Anaergia Announces Further Delay in the Filing of Audited Financial Statements and Related Disclosures

BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today that it will further delay filing its annual information form for the year ended December 31, 2022, audited annual consolidated financial statements for the year ended December 31, 2022, the related management’s discussion and analysis of financial condition and results of operations and CEO and CFO certificates relating to the audited annual financial statements as required by National Instrument 52-109 – Certificate of Disclosure in Issuers’ Annual and Interim Filings (collectively, the “Required Documents”) beyond the March 31, 2023 deadline.

During its audit of the Company’s annual consolidated financial statements, KPMG LLP (“KPMG”) identified a potential adjustment related to a change in the determination of the acquisition date of a business combination during the year from the third quarter to the second quarter of 2022, which may necessitate changes to the Company’s accounting for the acquisition.

The Company’s analysis of the impact of the change in the determination of the acquisition date and KPMG’s subsequent audit procedures on this analysis will not be completed prior to the March 31, 2023 filing deadline for the Required Documents. The Company is currently working diligently to complete the analysis and facilitate the completion of the audit of the annual consolidated financial statements by KPMG at the earliest possible date and currently expects to be in a position to file the Required Documents by April 10, 2023 or sooner.

Anaergia has also applied to the Ontario Securities Commission (the “OSC”), as principal regulator, for the imposition of a management cease trade order under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) throughout the duration of the default. However, there can be no assurance that a management cease trade order will be granted.

The management cease trade order, if approved, will generally not affect the ability of persons who are not or have not been management of Anaergia to trade in its securities.

Anaergia confirms that it will satisfy the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly default status reports, if necessary, in the form of news releases for so long as it remains in default of the above-noted filing requirements. The OSC may issue a general cease trade order against Anaergia for failure to file the Required Documents within the prescribed time period or sooner if Anaergia fails to file the prescribed status reports.

Anaergia confirms that there are no insolvency proceedings to which it is subject and there is no other material information relating to its affairs that has not been generally disclosed.

Other than as disclosed herein, Anaergia is up to date in its filing obligations.

About Anaergia

Anaergia was created to eliminate a major source of greenhouse gases by cost effectively turning organic waste into renewable natural gas (RNG), fertilizer and water, using proprietary technologies. With a proven track record from delivering world-leading projects on four continents, Anaergia is uniquely positioned to provide end-to-end solutions for extracting organics from waste, implementing high efficiency anaerobic digestion, upgrading biogas, producing fertilizer and cleaning water. Our customers are in the municipal solid waste, municipal wastewater, agriculture, and food processing industries. In each of these markets Anaergia has built many successful plants including some of the largest in the world. Anaergia owns and operates some of the plants it builds, and it also operates plants that are owned by its customers.

Forward-Looking Information

This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects the Company’s current expectations regarding future events, including statements relating to the Company’s process to obtain the Potential Financial. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s annual information form dated March 28, 2022 for the fiscal year ended December 31, 2021. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws.

For more information, please see: www.anaergia.com

Contacts

For media relations, please contact: Melissa Bailey, Director, Marketing & Corporate Communications, Melissa.Bailey@Anaergia.com

For investor relations, please contact: IR@Anaergia.com

#FOLLOW US ON INSTAGRAM